West Nile-Innovator + EWThis page contains information on West Nile-Innovator + EW for veterinary use.
The information provided typically includes the following:
- West Nile-Innovator + EW Indications
- Warnings and cautions for West Nile-Innovator + EW
- Direction and dosage information for West Nile-Innovator + EW
West Nile-Innovator + EWThis treatment applies to the following species:
Encephalomyelitis-West Nile Virus Vaccine
Eastern & Western, Killed Virus
This product has been shown to be effective for the vaccination of healthy horses 10 months of age or older against viremia caused by West Nile virus and encephalomyelitis caused by Eastern and Western viruses. A duration of immunity of at least 12 months has been demonstrated against West Nile virus.
Duration of immunity against the remaining fractions is unknown. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age. This product is also safe for use as a single dose during the third trimester of pregnancy.
Directions For Use
Shake well. Aseptically administer 1 mL intramuscularly. Healthy horses should receive two doses administered 3-4 weeks apart. For advice on revaccination frequency or in the face of stress or exposure, contact your veterinarian or the manufacturer.
PrecautionsStore at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. Contains formalin, thimerosal, neomycin, and polymyxin B as preservatives. Do not mix with other products. In case of human exposure, contact a physician.
Technical inquiries: (888) 963-8471
VLN 190/PCN 14W5.22
Zoetis Inc., Kalamazoo, MI 49007, USA
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Copyright © 2023 Animalytix LLC. Updated: 2023-05-29